Ultragenyx Pharmaceutical Inc. ($RARE)
Filing Information
| Accession Number | 0001193125-26-089282 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 4, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
22,182
Total Value
$240,289.20
P&L
+inf% (+$238,215.78)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP & Chief Commercial Officer | Common Stock | โ | Mar 1, 2026 | Grant/Award | 11,643 | $0.00 | $0.00 | 99,498 | Direct | โ | View Details | |
EVP & Chief Commercial Officer | Common Stock | โ | Mar 2, 2026 | Sale | 10,539 | $22.80 | $240,289.20 | 89,515 | Direct | โ | View Details |